Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Rare Twist: Post-rabies Vaccine Guillain-Barré Syndrome Unveiled

View through CrossRef
Guillain-Barre syndrome is an autoimmune neurological disorder characterized by rapid worsening weakness, often starting in the legs and spreading upward. Guillain-Barre syndrome is usually preceded by respiratory or gastrointestinal infections. Two-thirds of cases of Guillain-Barre syndrome are diagnosed following infection; however, vaccination has also been linked to Guillain-Barre syndrome pathogenesis. The most commonly known etiology of Guillain-Barre syndrome is an infectious disease notably caused by Campylobacter Jejuni. A very small fraction of people can develop Guillain-Barre syndrome due to vaccines such as meningococcal, poliovirus, influenza, and rabies. Vaccine-associated Guillain-Barre syndrome is defined as those with the onset of Guillain-Barre syndrome symptoms within six weeks after receiving the vaccine. Among the vaccines associated with Guillain-Barré Syndrome, one is for rabies. Given the invariably fatal nature of rabies, post-exposure prophylaxis should be administered in accordance with World Health Organization guidelines. There are two types of vaccines globally available to protect against rabies in humans; which are Nerve Tissue Vaccine 2 (NTV) and Cell Culture Vaccine (CCV). Even though, the World Health Organization has strongly recommended discontinuing the Nerve Tissue Vaccine and replace with the modern cell culture-derived vaccine, a few low-income countries including Ethiopia are still using the vaccine as post-exposure prophylaxis following rabies exposure, because of the affordability and accessibility problems related to modern cell culture vaccines. The vaccine has been predominantly used in Ethiopia since 1944. We are reporting a 22-year-old Ethiopian woman who presented with a progressive weakness for six days. The weakness initially started from the lower limb. It progressed caudally after she had received 12 doses of the Nerve Tissue anti-rabies vaccine, which was administered following a dog bite to her right lower extremity.
Title: Rare Twist: Post-rabies Vaccine Guillain-Barré Syndrome Unveiled
Description:
Guillain-Barre syndrome is an autoimmune neurological disorder characterized by rapid worsening weakness, often starting in the legs and spreading upward.
Guillain-Barre syndrome is usually preceded by respiratory or gastrointestinal infections.
Two-thirds of cases of Guillain-Barre syndrome are diagnosed following infection; however, vaccination has also been linked to Guillain-Barre syndrome pathogenesis.
The most commonly known etiology of Guillain-Barre syndrome is an infectious disease notably caused by Campylobacter Jejuni.
A very small fraction of people can develop Guillain-Barre syndrome due to vaccines such as meningococcal, poliovirus, influenza, and rabies.
Vaccine-associated Guillain-Barre syndrome is defined as those with the onset of Guillain-Barre syndrome symptoms within six weeks after receiving the vaccine.
Among the vaccines associated with Guillain-Barré Syndrome, one is for rabies.
Given the invariably fatal nature of rabies, post-exposure prophylaxis should be administered in accordance with World Health Organization guidelines.
There are two types of vaccines globally available to protect against rabies in humans; which are Nerve Tissue Vaccine 2 (NTV) and Cell Culture Vaccine (CCV).
Even though, the World Health Organization has strongly recommended discontinuing the Nerve Tissue Vaccine and replace with the modern cell culture-derived vaccine, a few low-income countries including Ethiopia are still using the vaccine as post-exposure prophylaxis following rabies exposure, because of the affordability and accessibility problems related to modern cell culture vaccines.
The vaccine has been predominantly used in Ethiopia since 1944.
We are reporting a 22-year-old Ethiopian woman who presented with a progressive weakness for six days.
The weakness initially started from the lower limb.
It progressed caudally after she had received 12 doses of the Nerve Tissue anti-rabies vaccine, which was administered following a dog bite to her right lower extremity.

Related Results

GUILLAIN-BARRÉ SYNDROME: CAUSES, EPIDEMIOLOGY, IMMUNOPATHOGENIC MECHANISMS, DIAGNOSIS, EVALUATION, DIFFERENTIAL AND TREATMENT
GUILLAIN-BARRÉ SYNDROME: CAUSES, EPIDEMIOLOGY, IMMUNOPATHOGENIC MECHANISMS, DIAGNOSIS, EVALUATION, DIFFERENTIAL AND TREATMENT
Introduction: Guillain-Barre syndrome is an uncommon, yet potentially fatal, immune-mediated disease affecting peripheral nerves and nerve roots that is commonly generated by infec...
The Status of Rabies Post Exposure Prophylaxis Using Nerve Tissue Anti-Rabies Vaccine in Ethiopia
The Status of Rabies Post Exposure Prophylaxis Using Nerve Tissue Anti-Rabies Vaccine in Ethiopia
The use of anti-rabies vaccine as post-exposure prophylaxis started during the year 1885 and play significant role in preventing rabies cases in humans. Since then, anti-rabies vac...
Knowledge, attitude, and practices associated with rabies in villages with different dog vaccination statuses in Cambodia
Knowledge, attitude, and practices associated with rabies in villages with different dog vaccination statuses in Cambodia
Background and Aim: Rabies is a highly infectious but neglected zoonotic disease. Almost 99% of rabies-related human deaths are caused by dog-mediated rabies. Although canine rabie...
Dysglycemia and Neurologic Outcome in Mechanically Ventilated Patients With Guillain-Barré Syndrome
Dysglycemia and Neurologic Outcome in Mechanically Ventilated Patients With Guillain-Barré Syndrome
Objectives: Acute respiratory failure is a frequent complication of Guillain-Barré syndrome, associated with high morbidity and mortality. Adjuvant treatments are neede...
Rabies Post Exposure Vaccine Effectiveness: A Retrospective Case–Control Study in Amhara Region, Ethiopia
Rabies Post Exposure Vaccine Effectiveness: A Retrospective Case–Control Study in Amhara Region, Ethiopia
Rabies can be prevented by vaccination of dogs and provision of post exposure vaccine (PEV) for exposed subjects. There are many post exposure rabies vaccines in the market with th...
Burden of the Beast
Burden of the Beast
Introduction Throughout the COVID-19 pandemic, and its fluctuating waves of infections and the emergence of new variants, Indigenous populations in Australia and worldwide have re...
Understanding Strategies for Implementing Integrated Information Systems for Rabies Surveillance
Understanding Strategies for Implementing Integrated Information Systems for Rabies Surveillance
Rabies continues to be one of the most perilous viral diseases that affect the nervous system and remains a significant threat to public health across the globe. Available data tha...

Back to Top